These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21434773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
    Miners JO, Mackenzie PI, Knights KM.
    Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glucuronidation of amine substrates by purified and expressed UDP-glucuronosyltransferase proteins.
    Green MD, Tephly TR.
    Drug Metab Dispos; 1998 Sep; 26(9):860-7. PubMed ID: 9733664
    [Abstract] [Full Text] [Related]

  • 5. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes.
    Kaivosaari S, Toivonen P, Aitio O, Sipilä J, Koskinen M, Salonen JS, Finel M.
    Drug Metab Dispos; 2008 Aug; 36(8):1529-37. PubMed ID: 18474681
    [Abstract] [Full Text] [Related]

  • 6. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.
    Green MD, King CD, Mojarrabi B, Mackenzie PI, Tephly TR.
    Drug Metab Dispos; 1998 Jun; 26(6):507-12. PubMed ID: 9616184
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.
    Itäaho K, Mackenzie PI, Ikushiro S, Miners JO, Finel M.
    Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240
    [Abstract] [Full Text] [Related]

  • 12. Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalyzed by expressed monkey UDP-glucuronosyltransferase 2B9 protein.
    Green MD, Bélanger G, Hum DW, Bélanger A, Tephly TR.
    Drug Metab Dispos; 1997 Dec; 25(12):1389-94. PubMed ID: 9394029
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases.
    Yan Z, Caldwell GW, Gauthier D, Leo GC, Mei J, Ho CY, Jones WJ, Masucci JA, Tuman RW, Galemmo RA, Johnson DL.
    Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
    Nishiyama T, Kobori T, Arai K, Ogura K, Ohnuma T, Ishii K, Hayashi K, Hiratsuka A.
    Arch Biochem Biophys; 2006 Oct 01; 454(1):72-9. PubMed ID: 16949544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.